Yonhap Infomax NewsApr 2
Korea Pharmaceutical and Bio-Pharma Manufacturers Association holds emergency meeting to address government's drug price reform, which cuts generic pricing rate from 53.55% to 45%, with gradual implementation until 2036 to minimize industry impact
#YonhapInfomax #DrugPriceReform #KoreaPharmaceuticalAssociation #GenericDrugs #MinistryOfHealthAndWelfare #PricingRate #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=113533
Korea Pharmaceutical and Bio-Pharma Manufacturers Association Vows to Minimize Industry Impact from Government Drug Price Cuts

Korea Pharmaceutical and Bio-Pharma Manufacturers Association holds emergency meeting to address government's drug price reform, which cuts generic pricing rate from 53.55% to 45%, with gradual implementation until 2036 to minimize industry impact

Yonhap Infomax
Yonhap Infomax NewsJan 27
The Emergency Committee on Drug Price Reform and the Federation of Korean Trade Unions have agreed to jointly oppose the government's proposed drug price cuts, warning of negative impacts on the pharmaceutical industry and labor market.
#YonhapInfomax #DrugPriceReform #FederationOfKoreanTradeUnions #PharmaceuticalIndustry #LaborMarket #PolicyReform #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=102279
Emergency Committee on Drug Price Reform, Federation of Korean Trade Unions to Jointly Respond to Government Drug Price Cuts

The Emergency Committee on Drug Price Reform and the Federation of Korean Trade Unions have agreed to jointly oppose the government's proposed drug price cuts, warning of negative impacts on the pharmaceutical industry and labor market.

Yonhap Infomax